296 related articles for article (PubMed ID: 32270932)
1. [Management of the antiphospholipid syndrome in adults].
Doms J; Horisberger A; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):670-674. PubMed ID: 32270932
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk in the antiphospholipid syndrome.
Lim W
Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
5. Current status and future prospects for the treatment of antiphospholipid syndrome.
Al Marzooqi A; Leone A; Al Saleh J; Khamashta M
Expert Rev Clin Immunol; 2016 Sep; 12(9):927-35. PubMed ID: 27117597
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
[TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG; Andreoli L; Limper M; Amoura Z; Cervera R; Costedoat-Chalumeau N; Cuadrado MJ; Dörner T; Ferrer-Oliveras R; Hambly K; Khamashta MA; King J; Marchiori F; Meroni PL; Mosca M; Pengo V; Raio L; Ruiz-Irastorza G; Shoenfeld Y; Stojanovich L; Svenungsson E; Wahl D; Tincani A; Ward MM
Ann Rheum Dis; 2019 Oct; 78(10):1296-1304. PubMed ID: 31092409
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome.
Amengual O; Atsumi T; Koike T
Curr Vasc Pharmacol; 2011 Sep; 9(5):606-18. PubMed ID: 21692741
[TBL] [Abstract][Full Text] [Related]
9. Serological evolution in women with positive antiphospholipid antibodies.
Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
[TBL] [Abstract][Full Text] [Related]
10. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
Kato M; Hisada R; Atsumi T
Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid syndrome.
Lim W
Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
[TBL] [Abstract][Full Text] [Related]
12. Current insights in obstetric antiphospholipid syndrome.
Schreiber K; Radin M; Sciascia S
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
[TBL] [Abstract][Full Text] [Related]
13. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
14. The antiphospholipid syndrome: from pathophysiology to treatment.
Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Antiphospholipid Syndrome.
Arachchillage DRJ; Pericleous C
Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
[TBL] [Abstract][Full Text] [Related]
16. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
[TBL] [Abstract][Full Text] [Related]
17. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome.
Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I
Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
Arachchillage DJ; Laffan M; Pericleous C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
[TBL] [Abstract][Full Text] [Related]
20. The antiphospholipid syndrome: still an enigma.
Chaturvedi S; McCrae KR
Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
